COGNEX CORP·4

Feb 24, 4:20 PM ET

MACDONALD LAURA ANN 4

4 · COGNEX CORP · Filed Feb 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Cognex (CGNX) VP Laura Ann MacDonald Exercises RSUs, Shares Withheld

What Happened
Laura Ann MacDonald, VP and Principal Accounting Officer of Cognex Corporation (CGNX), had restricted stock units (RSUs) convert into common shares on Feb 20–21, 2026. She converted a total of 4,656 RSUs (1,902 on Feb 20 and 2,754 on Feb 21). To satisfy tax withholding on the vested RSUs, 559 shares were withheld on Feb 20 and 809 shares were withheld on Feb 21 (total 1,368 shares), with the withheld shares valued at $56.03 each for total withholding value of $76,649. The conversions show $0 exercise price because RSUs convert to shares upon vesting rather than requiring a cash payment.

Key Details

  • Transaction dates: Feb 20, 2026 and Feb 21, 2026. Withheld price: $56.03 per share.
  • RSUs converted: 4,656 total (1,902 on Feb 20; 2,754 on Feb 21).
  • Shares withheld for taxes: 559 (Feb 20) and 809 (Feb 21) — total 1,368 shares; withholding proceeds = $31,321 and $45,328 respectively (total $76,649).
  • Filing: Form 4 filed Feb 24, 2026 — appears timely for the Feb 20–21 transactions.
  • Footnotes: Restricted stock units equal one share each (RSU → 1 share). Vesting schedules referenced: grants dated Feb 21, 2023 and Feb 20, 2024 (vesting ~20%/30%/50% across years). Some shares are reported as held by the reporting person's child (she disclaims beneficial ownership except for pecuniary interest).

Context

  • These transactions are RSU conversions upon vesting, not open-market purchases or voluntary sales (the withheld shares are routine tax withholding). This is common when awards vest: a portion of the award is surrendered or withheld to cover taxes.
  • The filing shows routine vesting and tax withholding; it does not by itself indicate a change in the insider’s market view.

Insider Transaction Report

Form 4
Period: 2026-02-20
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-20+1,9025,825 total
  • Tax Payment

    Common Stock

    [F1]
    2026-02-20$56.03/sh559$31,3215,266 total
  • Exercise/Conversion

    Common Stock

    2026-02-21+2,7548,020 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-21$56.03/sh809$45,3287,211 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F4][F5]
    2026-02-212,7540 total
    Exercise: $0.00From: 2024-02-21Exp: 2026-02-21Common Stock (2,754 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F4][F6]
    2026-02-201,9023,169 total
    Exercise: $0.00From: 2025-02-20Exp: 2027-02-20Common Stock (1,902 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: By Children)
    20
  • Non-Qualified Stock Option (right to buy)

    Exercise: $33.04From: 2026-02-18Exp: 2035-02-18Common Stock (33,168 underlying)
    33,168
  • Non-Qualified Stock Option (right to buy)

    Exercise: $39.44From: 2025-02-20Exp: 2034-02-20Common Stock (37,698 underlying)
    37,698
  • Non-Qualified Stock Option (right to buy)

    Exercise: $47.21From: 2024-02-21Exp: 2033-02-21Common Stock (30,492 underlying)
    30,492
  • Non-Qualified Stock Option (right to buy)

    Exercise: $48.28From: 2022-05-01Exp: 2029-05-01Common Stock (10,000 underlying)
    10,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $50.94From: 2021-02-18Exp: 2030-02-18Common Stock (42,500 underlying)
    42,500
  • Non-Qualified Stock Option (right to buy)

    Exercise: $51.49From: 2020-02-19Exp: 2029-02-19Common Stock (30,000 underlying)
    30,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $56.44From: 2019-02-20Exp: 2028-02-20Common Stock (15,000 underlying)
    15,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $57.09From: 2027-02-17Exp: 2036-02-17Common Stock (7,231 underlying)
    7,231
  • Non-Qualified Stock Option (right to buy)

    Exercise: $64.43From: 2023-02-22Exp: 2032-02-22Common Stock (23,891 underlying)
    23,891
  • Non-Qualified Stock Option (right to buy)

    Exercise: $90.50From: 2022-02-16Exp: 2031-02-16Common Stock (13,946 underlying)
    13,946
  • Restricted Stock Unit

    Exercise: $0.00From: 2025-03-15Exp: 2027-03-15Common Stock (982 underlying)
    982
  • Restricted Stock Unit

    Exercise: $0.00From: 2026-02-18Exp: 2028-02-18Common Stock (9,685 underlying)
    9,685
  • Restricted Stock Unit

    Exercise: $0.00From: 2027-02-17Exp: 2029-02-17Common Stock (11,211 underlying)
    11,211
Footnotes (6)
  • [F1]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.
  • [F2]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
  • [F3]Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
  • [F5]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
  • [F6]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.
Signature
Laura A. MacDonald|2026-02-24

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT